Welcome to our dedicated page for Innerscope Hear news (Ticker: INND), a resource for investors and traders seeking the latest updates and insights on Innerscope Hear stock.
InnerScope Hearing Technologies, Inc. (INND) is a Roseville-based innovator delivering B2B software solutions and consumer-focused hearing technologies. This page aggregates all official news and announcements related to INND's strategic initiatives, including its iHEAR Matrix OTC hearing aids and SAAS-based audiology practice tools.
Investors and industry stakeholders will find curated updates on financial performance, product launches, and regulatory developments shaping the $30B+ hearing aid market. Key coverage areas include earnings reports, retail distribution expansions, and technological advancements in personal sound amplification products.
Bookmark this page to efficiently monitor INND's progress in democratizing hearing healthcare through affordable, Bluetooth-enabled devices and practice management systems. Check regularly for analysis-neutral updates directly impacting the company's market position.
InnerScope Hearing Technologies (OTC: INND) announced a strategic alliance tied to Ainnova Tech's pending acquisition of OTCHealth on October 22, 2025. InnerScope will transition the majority of its day-to-day sales operations and its retail agreements with Walmart, CVS, Target, Walgreens and a network representing 15,000+ independent pharmacies to OTCHealth as a new Ainnova subsidiary.
InnerScope will receive equity and profit participation in OTCHealth and Ainnova post-acquisition, while refocusing on global R&D and hearing-technology integration with Ainnova's AI diagnostics and upcoming retinal camera to support earlier detection of vascular, neurological, and hearing-related conditions.
InnerScope Hearing Technologies (OTC: INND) has announced the launch of OTCHealthMart.com, a new online platform offering affordable health and wellness products. The e-commerce site features OTC hearing aids under HearingAssist and iHEAR brands, along with vitamins and health supplements specifically designed for the 55+ demographic.
The platform offers grand opening promotions including discounted pricing on bestselling products and free shipping on orders over $75. The company plans to expand its product line to include durable medical equipment (DME) in its next phase. The website aims to provide expert-curated products, competitive pricing, and educational resources to support customers' health journeys.
InnerScope Hearing Technologies (OTC: INND) has launched its HearingAssist brand of FDA-Registered OTC Rechargeable Hearing Aids on Walgreens.com. This strategic move is part of InnerScope's B2B sales growth strategy, allowing them to reach millions of Walgreens customers. The HearingAssist Rechargeable OTC Hearing Aids, priced between $499 and $799, promise affordability and high-quality features, including Bluetooth connectivity. With over 500,000 hearing aids sold, InnerScope aims to dominate the OTC market by enhancing access to effective hearing solutions.
InnerScope Hearing Technologies (OTC: INND) has launched its HearingAssist brand of FDA-registered Over-the-Counter (OTC) rechargeable hearing aids on Walgreens.com, expanding its market reach. This launch grants nationwide access to consumers seeking affordable hearing solutions, with prices ranging from $499 to $799 per pair. InnerScope claims to be America's #1 OTC hearing aid brand, having sold over 500,000 units. The new hearing aids feature advanced technology such as Bluetooth connectivity, enabling users to stream audio from smartphones. InnerScope's strategy focuses on increasing B2B sales through major retailers, positioning itself as a leader in the OTC hearing aid market.
InnerScope Hearing Technologies (OTC: INND) reported a profitable year-end 2022, highlighting consolidated net revenues of $15,284,327, gross profit of $9,079,335, and a net profit of $5,575,892. The company's EBITA stood at 36%, demonstrating strong operational efficiency. Driven by wholesale distribution agreements from its acquisitions of HearingAssist and iHEAR, InnerScope expanded its market presence significantly. In line with the FDA ruling enabling OTC hearing aids' sale without a prescription, InnerScope pivoted to a B2B model, enhancing its retail partnerships. The annual financial report is available on OTC Markets.
InnerScope Hearing Technologies (OTC: INND) has announced the launch of its HearingAssist brand of FDA-Registered Over-the-Counter (OTC) Rechargeable Hearing Aids on Target.com. This expansion aims to reach nearly 30 million Americans in need of hearing solutions. The HearingAssist devices are priced between $499 and $599, featuring Bluetooth technology and advanced sound enhancement capabilities. With over 500,000 hearing aids sold, InnerScope is positioned as a leader in the affordable OTC hearing aid market, benefitting from the recent OTC Hearing Aid Law. The launch on Target strengthens its market distribution through major retailers.
FAQ
What is the current stock price of Innerscope Hear (INND)?
What is the market cap of Innerscope Hear (INND)?
